Metformin Recall Advisory

Patient Advisory: HSA recalls 3 out of 46 Metformin Medicines on 4 Dec 2019   

1.         The Health Sciences Authority (HSA) recalled 3 metformin medicines – Glucient XR Tablet 500mg, Meijumet Prolonged Release Tablet 750mg and Meijumet Prolonged Release Tablet 1000mg. The 43 other brands of metformin medicines approved in Singapore are NOT affected by the recall. 

 

2.        These affected brands are not stocked at any pharmacies of the National Healthcare Group Polyclinics (NHGP). 

3.         If you have any of the affected medication, please contact the pharmacy where you purchased the medicines for instructions on the exchange. 

4.         There is no immediate health risk to you. Do not stop taking your medication on your own, as stopping your medication will lead to an increase in your blood sugar levels. 

5.         For more information on the recall, please refer to HSA’s website. Thank you.